{"id":"https://openalex.org/W4361909342","doi":"https://doi.org/10.1158/1078-0432.22454514.v1","title":"Supplemental Figure 4 from MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro","display_name":"Supplemental Figure 4 from MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361909342","doi":"https://doi.org/10.1158/1078-0432.22454514.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22454514.v1","doi":"https://doi.org/10.1158/1078-0432.22454514.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22454514.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22454514.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078819113","display_name":"Trevor E. Angell","orcid":"https://orcid.org/0000-0002-9929-0188","observed_orcids":["https://orcid.org/0000-0002-9929-0188"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Trevor E. Angell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077912416","display_name":"Melissa G. Lechner","orcid":"https://orcid.org/0000-0002-4744-6566","observed_orcids":["https://orcid.org/0000-0002-4744-6566"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa G. Lechner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005537053","display_name":"Julie K. Jang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie K. Jang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018510401","display_name":"Jonathan S. LoPresti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan S. LoPresti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077143749","display_name":"Alan L. Epstein","orcid":"https://orcid.org/0000-0002-1834-7729","observed_orcids":["https://orcid.org/0000-0002-1834-7729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan L. Epstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/papillary-thyroid-carcinoma","display_name":"papillary thyroid carcinoma","score":0.953000009059906},{"id":"https://openalex.org/keywords/mhc-class-i-loss","display_name":"MHC class I loss","score":0.9490000009536743},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.9649999737739563},{"id":"https://openalex.org/keywords/selumetinib","display_name":"selumetinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.8399999737739563},{"id":"https://openalex.org/keywords/antigen-processing-machinery","display_name":"antigen processing machinery","score":0.871999979019165},{"id":"https://openalex.org/keywords/tap1","display_name":"TAP1","score":0.8550000190734863},{"id":"https://openalex.org/keywords/stat1","display_name":"STAT1","score":0.9509999752044678},{"id":"https://openalex.org/keywords/stat6","display_name":"STAT6","score":0.9929999709129333},{"id":"https://openalex.org/keywords/lmp2","display_name":"LMP2","score":0.9200000166893005},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8460000157356262},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9890000224113464},{"id":"https://openalex.org/keywords/hla-abc","display_name":"HLA-ABC","score":0.8529999852180481},{"id":"https://openalex.org/keywords/beta2-microglobulin","display_name":"beta2-microglobulin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/thyroid-cancer-cell-lines","display_name":"thyroid cancer cell lines","score":0.8209999799728394},{"id":"https://openalex.org/keywords/k-1","display_name":"K-1","score":0.906000018119812}],"concepts":[{"id":"https://openalex.org/C2776087337","wikidata":"https://www.wikidata.org/wiki/Q7448840","display_name":"Selumetinib","level":5,"score":0.7343063354492188},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5333449840545654},{"id":"https://openalex.org/C2778814158","wikidata":"https://www.wikidata.org/wiki/Q959350","display_name":"MHC class II","level":4,"score":0.45986437797546387},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4464280307292938},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.436690092086792},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40638336539268494},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33873260021209717},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3384944796562195},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.33734357357025146},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.334506630897522},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.30448096990585327},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2793705463409424},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21575888991355896},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.13006815314292908},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12151932716369629}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22454514.v1","doi":"https://doi.org/10.1158/1078-0432.22454514.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22454514.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22454514.v1","doi":"https://doi.org/10.1158/1078-0432.22454514.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22454514.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6800000071525574,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2136498843","https://openalex.org/W4361944799","https://openalex.org/W3020956173","https://openalex.org/W3018872563","https://openalex.org/W2804878094","https://openalex.org/W2015129049","https://openalex.org/W2315643298","https://openalex.org/W1490210616","https://openalex.org/W2948616118","https://openalex.org/W3000243778"],"abstract_inverted_index":{"Supplemental":[0],"Figure":[1],"4.":[2],"Effect":[3],"of":[4,9,17,78,98,119,131,139,157],"Selumetinib":[5],"treatment":[6,55],"on":[7],"expression":[8,38,97,118,156],"antigen":[10],"processing":[11],"machinery":[12],"(APM),":[13],"cytokines,":[14],"signal":[15],"transducer":[16],"activation":[18],"and":[19,22,82,122,128,130,141,161,174],"transcription":[20],"(STAT),":[21],"MHC":[23],"class":[24],"I":[25],"molecule":[26],"genes":[27,100],"in":[28,36,39,96,103,126,133,145,153],"thyroid":[29,41],"cancer":[30,42],"cell":[31,43,74,106,147,167,184],"lines.":[32,148,185],"Mean":[33,149],"fold":[34,150],"change":[35,151],"gene":[37,155],"papillary":[40],"lines":[44,75],"(A)":[45],"BCPAP,":[46],"(B)":[47],"K-1,":[48,104,134],"or":[49],"(C)":[50],"TPC-1":[51,129],"following":[52],"selumetinib":[53,113,142],"(10\u03bcM)":[54],"relative":[56],"to":[57,112],"vehicle":[58],"control":[59],"is":[60,67],"shown":[61,170],"(statistical":[62],"significant":[63],"difference":[64],"from":[65],"1":[66],"indicated":[68],"by":[69,179],"an":[70],"asterix,":[71],"p<0.05).":[72],"All":[73],"showed":[76],"up-regulation":[77],"TAP1,":[79],"STAT1,":[80],"STAT6,":[81],"LMP2":[83],"with":[84],"selumetinib,":[85],"though":[86],"these":[87,146,183],"differences":[88],"did":[89],"not":[90],"meet":[91],"statistical":[92],"significance.":[93],"Notably,":[94],"increases":[95,152],"APM":[99],"were":[101],"greatest":[102,109],"the":[105,117,136,154],"line":[107,168],"showing":[108],"phenotypic":[110,176],"response":[111],"treatment.":[114],"In":[115],"addition,":[116],"IFN\u03b3,":[120],"IFN\u03b11A,":[121],"IFN\u03b12A":[123,132],"was":[124],"down-regulated":[125],"BCPAP":[127],"supporting":[135],"additive":[137],"effect":[138],"interferon":[140],"therapy":[143],"seen":[144],"HLA-A,":[158],"B,":[159],"C":[160],"beta-2":[162],"microglobulin":[163],"(\u03b22m)":[164],"for":[165,171,182],"each":[166],"are":[169],"illustration":[172],"purposes":[173],"paralleled":[175],"changes":[177],"observed":[178],"flow":[180],"cytometry":[181]},"counts_by_year":[],"updated_date":"2026-09-05T08:02:43.246662","created_date":"2023-04-05T00:00:00"}